Stifel Nicolaus reissued their buy rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. They currently have a $101.00 price objective on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on BMRN. Cantor Fitzgerald reduced […]
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Director Sells $939,900 00 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Stifel Nicolaus reiterated their buy rating on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a report published on Thursday morning, Benzinga reports. Stifel Nicolaus currently has a $101.00 price objective on the biotechnology company’s stock. A number of other equities analysts have also weighed in on the company. StockNews.com assumed coverage on BioMarin […]
BioMarin reached a
settlement with activist investor Elliott Investment Management
where the biotechnology company will add three independent
directors to its board and form a committee to.
Will resurgent shareholder activism help reignite the biotech sector? ifamagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ifamagazine.com Daily Mail and Mail on Sunday newspapers.